Page last updated: 2024-08-25

rosiglitazone and HIV

rosiglitazone has been researched along with HIV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alonso-Villaverde, C; Camps, J; Castro Cabezas, M; Coll, B; de Koning, EJ; Ferre, N; Hoepelman, IM; Joven, J; Parra, S; Rabelink, TJ; Tous, M; van Wijk, JP	1

Trials

1 trial(s) available for rosiglitazone and HIV

Article	Year
Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy. European journal of pharmacology, 2006, Aug-21, Volume: 544, Issue:1-3 Topics: Adult; Anti-Inflammatory Agents; Antioxidants; Aryldialkylphosphatase; Chemokine CCL2; Cholesterol, HDL; HIV; HIV Infections; Humans; Hypoglycemic Agents; Lipodystrophy; Male; Metformin; Middle Aged; Postprandial Period; Rosiglitazone; Thiazolidinediones	2006

Article

Year

Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy.

European journal of pharmacology, 2006, Aug-21, Volume: 544, Issue:1-3

Topics: Adult; Anti-Inflammatory Agents; Antioxidants; Aryldialkylphosphatase; Chemokine CCL2; Cholesterol, HDL; HIV; HIV Infections; Humans; Hypoglycemic Agents; Lipodystrophy; Male; Metformin; Middle Aged; Postprandial Period; Rosiglitazone; Thiazolidinediones

2006